Alcon marks five years of support for Contact Lens Assessment in Youth (CLAY) team
Nov 12, 2014
Alcon has provided nearly $700,000 to support CLAY research, focusing on understanding risk factors associated with contact lens complications
Research from the CLAY team has generated six peer-reviewed manuscripts and more than 20 conference presentations
FORT WORTH, Texas, November 12, 2014– Alcon, the global leader in eye care, is marking five years of unrestricted grant support for the Contact Lens Assessment in Youth (CLAY) team. Alcon has provided nearly $700,000 to advance the important research of the CLAY team since 2009.
The team's early research focused on determining whether youth is an independent risk factor for contact lens complications, and has since expanded toward understanding risk factors associated with contact lens complications in both children and adults to promote healthy contact lens wear for all ages.
"Without the generous support from Alcon the CLAY research would not have been possible," said CLAY co-chair, Heidi Wagner, OD, MPH, FAAO. "We have been able to isolate age as its own risk factor for contact lens complications, but also to focus the industry's attention on compliance and a deeper understanding of real world contact lens wearing experiences."
Since CLAY was first formed in 2008, researchers have generated six peer-reviewed manuscripts and over 20 conference presentations. Two presentations will be shared at the Annual Meeting of the American Academy of Optometry on Nov. 13 in Denver.
Contact Lens Assessment in Youth: Multi-Center Testing of a Risk Assessment Survey for Soft Contact Lens Wearers with Adverse Events
Presenter: Luigina Sorbara, OD , MSc, FAAO
Contact Lens Assessment in Youth Case-Control Pilot Study of Patients with Symptomatic Corneal Inflammatory Events
Presenter: Kathryn Richdale, OD, PhD, FAAO
"The research coming from this team is critical for understanding how youth and adults really use contact lenses, including potential barriers that our industry may be able to address," said Eric Bruno, Vice President and General Manager for US Vision Care at Alcon. "For Alcon, we are able to use insights from this type of research to inform our own patient education efforts around contact lens hygiene, lens care compliance and general contact lens wear."
Some other key areas of learning from the CLAY study team projects include the development of a standardized contact lens risk survey (CLRS), as well as a greater understanding of contact lens wear, care and access and behaviors unique to college wearers.
About Contact Lens Assessment in Youth (CLAY) team The CLAY team is comprised of cornea and contact lens researchers in academic centers across North America and was formed at the 2008 AOA-AAO Summer Research Institute. The group aims to understand risk factors associated with contact lens complications, and to explore means to modify them in order promote healthy contact lens wear for all ages.
- Kathryn Richdale, OD, PhD, FAAO (State University of New York College of Optometry, New York, NY) - Heidi Wagner, OD, MPH, FAAO, Dipl. (Nova Southeastern University College of Optometry, Ft. Lauderdale, FL) - Beth T. Kinoshita, OD, FAAO, Dipl. (Pacific University College of Optometry, Forest Grove, OR) - Dawn Y. Lam, MSc, OD, FAAO (Southern California College of Optometry at Marshall B. Ketchum University, Fullerton, CA) - Luigina Sorbara, OD, MSc, FAAO, Dipl. (University of Waterloo School of Optometry and Vision Science, Waterloo, ON, Canada) - Aaron Zimmerman, OD, MS, FAAO (The Ohio State University College of Optometry, Columbus, OH) - Robin L. Chalmers, OD, FAAO (Clinical Trial Consultant, Atlanta, Georgia) - G. Lynn Mitchell, MAS, FAAO (The Ohio State University College of Optometry, Columbus, OH)
About Alcon: Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. Alcon’s three businesses – Surgical, Pharmaceutical, and Vision Care – offer the widest spectrum of eye care products in the world. Alcon is the second largest division of the Novartis Group, with net sales of USD 10.5 billion in 2013. Headquartered in Fort Worth, Texas, USA, Alcon has more than 25,000 employees worldwide, operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com.